Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-05

Clinical Trial Update: Topical NVN1000 for the Treatment of External Genital and Perianal Warts [Phase 2]

View source ↗

Summary

Phase 2 trial of topical NVN1000 for external genital and perianal warts completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NVN1000 (NVN1000)

Snippet

Sponsor: Novan, Inc. | Conditions: Genital Warts, Perianal Warts | Phase 2 | Status: COMPLETED | Results posted: 2023-04-05